TANDEM DIABETES CARE INCTANDEM DIABETES CARE INCTANDEM DIABETES CARE INC

TANDEM DIABETES CARE INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−12.61MXN
Revenue estimate
‪2.89 B‬MXN
Market capitalization
‪39.14 B‬MXN
−58.36MXN
‪−3.78 B‬MXN
‪12.70 B‬MXN
‪64.13 M‬
Beta (1Y)
1.66

About Tandem Diabetes Care, Inc.

CEO
John F. Sheridan
Headquarters
San Diego
Employees (FY)
‪2.4 K‬
Founded
2006
FIGI
BBG0166TWDL8
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TNDM is 807.19 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange TANDEM DIABETES CARE INC stocks are traded under the ticker TNDM.
TANDEM DIABETES CARE INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
TNDM stock is 0% volatile and has beta coefficient of 1.66. Check out the list of the most volatile stocks — is TANDEM DIABETES CARE INC there?
TNDM earnings for the last quarter are −8.89 MXN per share, whereas the estimation was −8.36 MXN resulting in a −6.40% surprise. The estimated earnings for the next quarter are −4.59 MXN per share. See more details about TANDEM DIABETES CARE INC earnings.
TANDEM DIABETES CARE INC revenue for the last quarter amounts to ‪3.24 B‬ MXN despite the estimated figure of ‪3.36 B‬ MXN. In the next quarter revenue is expected to reach ‪3.46 B‬ MXN.
Yes, you can track TANDEM DIABETES CARE INC financials in yearly and quarterly reports right on TradingView.
TNDM stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in TANDEM DIABETES CARE INC price.
TNDM net income for the last quarter is ‪−509.59 M‬ MXN, while the quarter before that showed ‪−574.53 M‬ MXN of net income which accounts for 11.30% change. Track more TANDEM DIABETES CARE INC financial stats to get the full picture.
Today TANDEM DIABETES CARE INC has the market capitalization of ‪39.14 B‬, it has decreased by 8.10% over the last week.
No, TNDM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TNDM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TANDEM DIABETES CARE INC stock right from TradingView charts — choose your broker and connect to your account.
TNDM reached its all-time high on May 4, 2022 with the price of 2366.04 MXN, and its all-time low was 807.19 MXN and was reached on Dec 14, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪2.40 K‬ employees. See our rating of the largest employees — is TANDEM DIABETES CARE INC on this list?
We've gathered analysts' opinions on TANDEM DIABETES CARE INC future price: according to them, TNDM price has a max estimate of 1024.99 MXN and a min estimate of 307.50 MXN. Read a more detailed TANDEM DIABETES CARE INC forecast: see what analysts think of TANDEM DIABETES CARE INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TANDEM DIABETES CARE INC EBITDA is ‪−2.36 B‬ MXN, and current EBITDA margin is −18.56%. See more stats in TANDEM DIABETES CARE INC financial statements.